George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,708.60
Bid: 1,708.40
Ask: 1,708.80
Change: 3.40 (0.20%)
Spread: 0.40 (0.023%)
Open: 1,701.60
High: 1,713.00
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

13 May 2014 15:30

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
13 May 2014 13:11

UK MIDDAY BRIEFING: AstraZeneca Continues To Reject Pfizer

LONDON (Alliance News) - AstraZeneca Tuesday again rejected Pfizer's "opportunistic" GBP63 million takeover approach, as UK politicians grilled executives of both companies about the potential deal and what it will mean for the UK's pharmaceutical industry.

Cruciall

Read more
13 May 2014 10:21

TOP NEWS: AstraZeneca Notes Positive Drug Test Amid Pfizer Hearing

LONDON (Alliance News) - The following is a summary of top news stories Tuesday.
----------
COMPANIES
----------
AstraZeneca PLC announced positive results from its late-stage study of combination treatment saxagliptin and dapagliflozin for

Read more
13 May 2014 08:55

UPDATE 1-Chinese police to brief media on GlaxoSmithKline on Wednesday amid probe

(Adds GSK declines to comment) BEIJING, May 13 (Reuters) - Chinese police will brief the media on Wednesday about British drug maker GlaxoSmithKline PLC , which has been under investigation for allegedly funneling up to 3 billion yuan to travel agencies to facilitate bribes to doctors and o

Read more
13 May 2014 08:27

Chinese police to brief media on GlaxoSmithKline on Wednesday amid probe

BEIJING, May 13 (Reuters) - China's Ministry of Public Security will brief the media on Wednesday about UK drug maker GlaxoSmithKline PLC, which has been under investigation for allegedly funneling up to 3 billion yuan to travel agencies to facilitate bribes to doctors and officials. An off

Read more
13 May 2014 07:30

GSK study of coronary heart disease treatment fails to meet objectives

GlaxoSmithKline said its phase III study of darapladib failed to meet the primary endpoint in treating patients with acute coronary syndrome. The study with darapladib, SOLID-TIMI 52, evaluating the efficacy of its investigational Lp-PLA2 inhibitor, did not achieve a reduction of major coronary pro

Read more
13 May 2014 07:29

UK MORNING BRIEFING: Taylor Wimpey Leads Strong FTSE 250

LONDON (Alliance News) - Mid-cap stocks are leading London equities higher at the open Tuesday, following a strong lead in from the US and Asia, particularly Tokyo.

Taylor Wimpey is leading the mid-cap FTSE 250, up 5.7%, after saying it expects to deliver a big incr

Read more
13 May 2014 06:56

GlaxoSmithKline Heart Disease Treatment Fails Late Stage Trial

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday its Phase III study for drug darapladib in the treatment of acute coronary syndrome failed to meet its primary endpoint of reducing major coronary events compared to a placebo when added to standard care. The company said that the ov

Read more
13 May 2014 06:40

GSK says heart drug darapladib fails in second late-stage trial

LONDON, May 13 (Reuters) - GlaxoSmithKline said its drug darapladib had not reduced heart attacks or other major events in patients with acute coronary syndrome, marking another disappointment for the innovative heart medicine. Darapladib had already failed in a late-stage trial for patient

Read more
13 May 2014 05:11

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
12 May 2014 15:16

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
12 May 2014 11:55

RPT-Fitch: 1Q14 European Big Pharma Dashboard

(Repeat for additional subscribers) May 12 (Reuters) - (The following statement was released by the rating agency) Fitch Ratings has published its 1Q14 European Big Pharma Dashboard. The publication explores major topics affecting issuer credit profiles for the sector in Europe

Read more
12 May 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
11 May 2014 16:00

Allergan rebuffed in seeking offers to combat Valeant bid-report

(Refiled to remove extraneous text characters in headline) May 11 (Reuters) - U.S. medical firm Allergan Inc declined to comment on Sunday on a report that it has been seeking offers from rival companies to combat Valeant Pharmaceuticals International's $47 billion cash and share offer.Read more

9 May 2014 15:13

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more

Quickpicks are a member only feature

Login to your account